SecBot SecBot

FLSC

Frazier Life Sciences Acquisition Corp. II
Nasdaq· CIK 0002153598
$10.30 +0.03 (+0.29%)
Oct 23 4:00 PM ET · prev $10.27
Since first trade
+0.1%
from $10.29 · Oct 14
30 days
+0.1%
from $10.29
Range since listing
$10.27–10.49
−2% from high · low Oct 22
Avg volume 8D
207.6K
Oct 14 spike 1.22M
Insider net
+$3.0M
1 buyer · 0 sellers · 12 mo
Filing reports
14
analyzed by SecBot
SecBot read MIXED 14 reports · 90 days
Balance 0 bearish · 1 bullish · 13 neutral oldest → newest, height = score
Avg score ·High conf. 13/14
Strongest BULLISH CEO Albert Cha purchased $3.00M of FLSC Class A shares at $10.00/share on the IPO closing date, October 15…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $3.0M at an average $10.00. No open-market sales.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 22, 2026 SEC
This 8-K reports the consummation of Frazier Life Sciences Acquisition Corp. II's IPO on October 15, 2026, and…
8-K — Impact 2/10
Oct 22, 2026 SEC
RA Capital Management, L.P. and affiliated entities disclosed a 9.0% passive stake in Frazier Life Sciences…
SC 13G — Impact 4/10
Oct 21, 2026 SEC
Frazier Life Sciences Holdings II LLC (the sponsor) filed a Schedule 13D disclosing beneficial ownership of 1,983,749…
SC 13D — Impact 2/10
Oct 15, 2026 Insider
Cha Albert bought 300,000 shares
Chief Executive Officer @ $10.00 ($3.0M)
Oct 14, 2026 Listing status
New Listing: FLSC — Frazier Life Sciences Acquisition Corp. II - Class A Ordinary Shares
Listed on exchange Q

Insider ledger

Form 4
$3.0M
bought · 1 insider
$0
sold · 0 insiders
+3.0%
vs their $10.00 cost
DateInsiderTypeValue
Oct 15, 2026
Cha Albert
Chief Executive Officer
BUY$3.0M

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 14, 2026
Listing
New Listing: FLSC — Frazier Life Sciences Acquisition Corp. II - Class A Ordinary Shares
Listed on exchange Q

SecBot reports

14 filings · 1 bullish · 0 bearish · 13 neutral
All FLSC filing & press-release reports (14)